title: Ipilimumab in a patient with known Crohn's disease: to give or not to give?
authors.affiliation: Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: Eric A R
authors.initials: EA
authors.lastname: Gielisse
authors.affiliation: Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: KHN.deBoer@vumc.nl.
authors.forename: Nanne K H
authors.initials: NK
authors.lastname: de Boer
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000930:Antidiarrheals / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003092:Colitis / Q000139:chemically induced / Q000188:drug therapy; D003424:Crohn Disease / Q000150:complications*; D016099:Endoscopy, Gastrointestinal; D006801:Humans; D000074324:Ipilimumab; D008139:Loperamide / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000930:Antidiarrheals; D000970:Antineoplastic Agents; D000074324:Ipilimumab; D008139:Loperamide